Mink Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +49.6% | +41.6% | +56.2% | +68.1% | +5.3% | -15.6% | |
| – | -60.0% | +1,886.5% | +73.5% | +27.5% | -53.1% | +47.7% | |
| – | +400.6% | +113.1% | -77.7% | – | – | – | |
| – | -107.9% | – | +134.6% | -67.0% | -84.1% | +615.4% | |
| – | -77.7% | +161.5% | +0.4% | -70.6% | -100.0% | -100.0% | |
| – | -77.7% | +161.5% | +0.4% | -70.6% | – | – | |
| – | – | – | – | +203.9% | -100.0% | – | |
| – | -2.9% | -14.8% | -100.0% | – | – | -100.0% | |
| – | -2.9% | +343.5% | -100.3% | +161.7% | – | +36.1% | |
| – | – | +1,413.2% | -153.2% | – | – | +626.0% | |
| – | – | – | – | – | – | – |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.